Clasificar por
Keyphrases
Angiotensin II (Ang II)
41%
Angiotensin-(1-7)
54%
Bile Acids
27%
CCN2
17%
Cholic Acid
19%
Chronic Liver Disease
19%
Connective Tissue Growth Factor
18%
Decorin
17%
Deoxycholic Acid
19%
Duchenne muscular Dystrophy
20%
Endothelial Cells
50%
Endotoxemia
22%
Endotoxin
32%
Fibroblasts
21%
Fibrosis
75%
Fibrotic Response
15%
Mas Receptor
36%
Mdx Mice
18%
Mitochondrial Dysfunction
14%
Molecular Mechanism
15%
Muscle Mass
20%
Muscle Strength
32%
Muscle Wasting
17%
Muscular Dystrophy
22%
Myoblast
21%
Myonuclear Apoptosis
16%
Myosin Heavy Chain (MyHC)
15%
Myotubes
20%
NAD(P)
14%
NF-B
19%
Non-alcoholic Fatty Liver Disease (NAFLD)
19%
Oxidase
14%
Oxidative Stress
48%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
16%
Pathological Conditions
18%
Protein Level
15%
Reactive Oxygen Species
22%
Renin-angiotensin System
27%
Sarcopenia
39%
Sepsis
29%
Skeletal muscle
75%
Skeletal muscle Atrophy
59%
Skeletal muscle Cells
36%
Skeletal muscle Wasting
20%
TGR5
16%
Transforming Growth Factor-β
100%
Transforming Growth factor-β1 (TGF-β1)
16%
TRPM7
20%
Ubiquitin-proteasome System
16%
Vascular Endothelial Cells
15%
Pharmacology, Toxicology and Pharmaceutical Science
Andrographolide
14%
Angiotensin
27%
Angiotensin II
35%
angiotensin[1-7]
59%
Atrogin 1
11%
Bile Acid
24%
Calcium Channel
8%
Calcium Ion
8%
Cholic Acid
9%
Chronic Liver Disease
30%
Connective Tissue Growth Factor
21%
Cytokine
15%
Deoxycholic Acid
14%
Disease
15%
Duchenne Muscular Dystrophy
16%
Endothelial Dysfunction
13%
Endotoxemia
22%
Endotoxin
28%
Fibrinogen
14%
Fibrosis
65%
Growth Hormone
9%
High Density Lipoprotein
19%
Hypotension
10%
Inflammation
28%
Inflammatory Disease
8%
Ion Channel
14%
Lipopolysaccharide
19%
Liver Disease
9%
Mouse
70%
Multiple Organ Failure
10%
Muscle Atrophy
77%
Muscle Disease
9%
Muscular Dystrophy
25%
Myosin Heavy Chain
19%
Nonalcoholic Fatty Liver
15%
Oxidoreductase
14%
Proteasome
11%
Reactive Oxygen Metabolite
36%
Receptor
83%
Renin
18%
Sarcopenia
36%
Sepsis
28%
Somatomedin C
13%
TGF-Beta
10%
Transforming Growth Factor
33%
Transforming Growth Factor Beta
35%
Transforming Growth Factor Beta Receptor 1
10%
Transforming Growth Factor Beta1
11%
Transient Receptor Potential Channel M4
9%
Ubiquitin
11%
Medicine and Dentistry
Angiotensin II
24%
Bile Acid
9%
Cell Migration
9%
Cell Therapy
11%
Chronic Liver Disease
12%
Connective Tissue Growth Factor
12%
Disease
14%
Disseminated Intravascular Coagulation
9%
Duchenne Muscular Dystrophy
11%
Endothelial Cell
42%
Endotoxemia
13%
Endotoxin
27%
Fibrinogen
9%
Fibroblast
20%
Fibrosis
54%
Gene Expression
9%
High-Density Lipoprotein
9%
Hypotension
10%
Ion Channel
8%
Lipid Diet
9%
Lipopolysaccharide
14%
Muscle Atrophy
31%
Muscle Regeneration
9%
Muscle Strength
14%
Muscular Dystrophy
24%
Myotube
9%
Nonalcoholic Fatty Liver
19%
Oxidative Stress
36%
Oxidoreductase
18%
Programmed Cell Death
17%
Proteasome
8%
Protein Expression
8%
Reactive Oxygen Species
23%
Receptor
16%
Receptor Potential
19%
Renin Angiotensin Aldosterone System
13%
Sarcopenia
25%
Sepsis
22%
Serositis
9%
Signal Transduction
17%
Skeletal Muscle
69%
Skeletal Muscle Atrophy
24%
Skeletal Muscle Cell
10%
Somatomedin C
8%
Transforming Growth Factor
19%
Transforming Growth Factor Beta
25%
Transforming Growth Factor Beta Receptor 1
10%
Transient Receptor Potential Channel M4
9%
Ubiquitin
8%
Vascular Endothelial Cell
14%
